These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. CCR drug updates: sorafenib and sunitinib in renal cell carcinoma. Stein MN; Flaherty KT Clin Cancer Res; 2007 Jul; 13(13):3765-70. PubMed ID: 17606705 [No Abstract] [Full Text] [Related]
7. Two new drugs for renal cell carcinoma. Med Lett Drugs Ther; 2007 Feb; 49(1255):18-20. PubMed ID: 17325624 [No Abstract] [Full Text] [Related]
8. [Renal cell carcinoma]. Oya M Gan To Kagaku Ryoho; 2010 Jan; 37(1):29-31. PubMed ID: 20140991 [No Abstract] [Full Text] [Related]
9. Newly approved therapies for RCC and their effect on the standard of care. Figlin RA Clin Adv Hematol Oncol; 2007 Jan; 5(1):35-6, 66. PubMed ID: 17339824 [No Abstract] [Full Text] [Related]
16. The reverse side of the victory: flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases. Desar IM; Mulder SF; Stillebroer AB; van Spronsen DJ; van der Graaf WT; Mulders PF; van Herpen CM Acta Oncol; 2009; 48(6):927-31. PubMed ID: 19452305 [No Abstract] [Full Text] [Related]
17. [Role of VEGFR-TKIs in the treatment of renal cell carcinoma]. Kondo T Nihon Jinzo Gakkai Shi; 2012; 54(5):574-80. PubMed ID: 22991835 [No Abstract] [Full Text] [Related]
18. Progress in the management of advanced renal cell carcinoma (RCC). Tong TQ; Rohde D; Peter S Aktuelle Urol; 2010 Jan; 41 Suppl 1():S57-60. PubMed ID: 20094957 [TBL] [Abstract][Full Text] [Related]
19. Health policy: The UK 'postcode lottery' in renal cell carcinoma. Larkin J; Gore M Nat Rev Urol; 2009 Dec; 6(12):636-8. PubMed ID: 19956190 [No Abstract] [Full Text] [Related]
20. [Molecular basis of targeted therapy in metastatic renal cancer]. Moch H Pathologe; 2008 Nov; 29 Suppl 2():184-6. PubMed ID: 18751979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]